<h2 id="Headline">
 Headline
</h2>
<h3 id="Tubulin_code__a_long_sought_after_player_identified">
 Tubulin code: a long sought-after player identified
</h3>
<p>
 In eukaryotes, the
 <a href="https://www.nature.com/scitable/topicpage/microtubules-and-filaments-14052932">
  cytoskeleton
 </a>
 helps cells maintain their shape and internal organization, and provides mechanical support that enables cells to carry out essential functions, like division and movement. It is made of filamentous proteins, microtubules being the largest type of cytoskeletal filament. Microtubules are dynamically assembled from alpha-tubulin and beta-tubulin heterodimers, creating specific structures adapted to the cell's needs, structures that can be as different from each other as a cilium can be from a mitotic spindle. How is this variety achieved using the same highly conserved building blocks? Part of the answer lies in the so-called
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/28325758">
  'tubulin code'
 </a>
 which involves not only the differential expression of alpha-and beta-tubulin genes (tubulin isotypes), but also a plethora of post-translational modifications (PTMs). Tubulins have a globular core and a more variable C-terminal tail that is exposed at the microtubule surface, where many PTMs occur. One of first PTMs to be reported, back in the 70s, was C-terminal
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/1204603,838053">
  reversible detyrosination
 </a>
 , which occurs on most alpha-, but not beta-, tubulins. The enzyme catalyzing the addition of tyrosine,
 <a href="http://www.uniprot.org/uniprot/?query=gene%5Fexact:ttl+taxonomy:mammalia+reviewed:yes">
  tubulin-tyrosine ligase or TTL
 </a>
 , was
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/7390974">
  identified not long after
 </a>
 , but the carboxypeptidase responsible for tubulin detyrosination remained elusive until recently.
</p>
<p>
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/29146868">
  Aillaud et al.
 </a>
 tackled the problem by developing an irreversible inhibitor of tubulin carboxypeptidase activity, followed by mass spectrometry analysis of the inhibitor targets.
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/29146869">
  Nieuwenhuis et al.
 </a>
 performed gene-trapping mutagenesis in a haploid human cell line aimed at regulators of tubulin detyrosination. Both groups identified
 <a href="http://www.uniprot.org/uniprot/?query=(gene:vash1+or+gene:vash2)+reviewed:yes">
  vasohibin-1 (VASH1) and 2 (VASH2)
 </a>
 as the major alpha-tubulin-specific carboxypeptidases.
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/23100270">
  Vasohibins
 </a>
 were formerly predicted to have a protease fold, but their enzymatic activity had not been investigated. Actually, both enzymes show low carboxypeptidase activity when assayed on their own. Full activity requires the formation of a complex with another protein, called
 <a href="http://www.uniprot.org/uniprot/?query=gene:svbp+reviewed:yes">
  small vasohibin-binding protein, or SVBP
 </a>
 . This may explain why previous attempts to identify tubulin carboxypeptidase have failed. SVBP-VASH complexes act preferentially on polymerized tubulins. When microtubules disassemble, TTL adds back a tyrosine residue at the C-terminus and the tubulin detyrosination/tyrosination cycle is closed.
</p>
<p>
 The physiological importance of detyrosination has to be investigated. SVBP or vasohibin knockdown in mouse hippocampal neurons results in delayed axonal differentiation. In embryos, it affects neuronal migration during brain cortex differentiation. However,
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/19204325">
  mice lacking VASH1 or VASH2
 </a>
 do not exhibit a dramatic phenotype. It should also be noted that vasohibin depletion in cells could not completely abolish activity, suggesting the existence of yet another enzyme.
</p>
<p>
 The
 <a href="http://www.uniprot.org/uniprot/?query=(gene:vash1+or+gene:vash2)+reviewed:yes">
  VASH1 and VASH2
 </a>
 protein entries have been updated and are now available in UniProtKB/Swiss-Prot.
</p>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05290">
   Cardiomyopathy, familial hypertrophic 27
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05276">
   Charcot-Marie-Tooth disease 2DD
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05283">
   Ciliary dyskinesia, primary, 38
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05275">
   Coffin-Siris syndrome 7
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05282">
   Congenital disorder of glycosylation 1BB
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05267">
   Corneal dystrophy, posterior polymorphous, 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05295">
   Diabetes mellitus, insulin-dependent, 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-00437">
   Ehlers-Danlos syndrome, classic type, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05270">
   Epileptic encephalopathy, early infantile, 65
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05273">
   Epileptic encephalopathy, infantile or early childhood, 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05271">
   Glycosylphosphatidylinositol biosynthesis defect 17
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05281">
   Humerofemoral hypoplasia with radiotibial ray deficiency
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05285">
   Hydrocephalus, congenital, 3, with brain anomalies
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05272">
   Hyperekplexia 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05291">
   Intellectual developmental disorder with or without epilepsy or cerebellar ataxia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05268">
   Leukodystrophy, hypomyelinating, 17
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05277">
   Mastocytosis, cutaneous
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05278">
   Mastocytosis, systemic
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05289">
   Mental retardation, autosomal dominant 57
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05269">
   Neurodevelopmental disorder with brain, liver, and lung abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05294">
   Otitis media
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05288">
   Parkinsonism-dystonia, infantile, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05279">
   Pelger-Huet anomaly with mild skeletal anomalies
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05292">
   Polycystic kidney disease 6 with or without polycystic liver disease
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05293">
   Pontocerebellar hypoplasia 1D
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05287">
   Proteasome-associated autoinflammatory syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05286">
   Proteasome-associated autoinflammatory syndrome 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05274">
   Protoporphyria, erythropoietic, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05284">
   Seizures, benign familial infantile, 6
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05280">
   Tetraamelia syndrome 2
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Acne inversa, familial, 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02996">
   Acne inversa, familial, 2, with or without Dowling-Degos disease
  </a>
 </li>
 <li>
  Anorexia nervosa 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04568">
   Anorexia nervosa
  </a>
 </li>
 <li>
  Cold-induced sweating syndrome 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01356">
   Crisponi/Cold-induced sweating syndrome 1
  </a>
 </li>
 <li>
  Cold-induced sweating syndrome 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01357">
   Crisponi/Cold-induced sweating syndrome 2
  </a>
 </li>
 <li>
  Cold-induced sweating syndrome 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04779">
   Crisponi/Cold-induced sweating syndrome 3
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00438">
   Ehlers-danlos syndrome, hypermobility type
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome 4 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00439">
   Ehlers-Danlos syndrome, vascular type
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome 6 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00440">
   Ehlers-Danlos syndrome, kyphoscoliotic type, 1
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome 7A -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00442">
   Ehlers-Danlos syndrome, arthrochalasia type, 1
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome 7C -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00444">
   Ehlers-Danlos syndrome, dermatosparaxis type
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01317">
   Ehlers-Danlos syndrome, cardiac valvular type
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome, classic type -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00436">
   Ehlers-Danlos syndrome, classic type, 1
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome due to tenascin X deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01097">
   Ehlers-Danlos syndrome, classic-like
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome, progeroid type, 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03844">
   Ehlers-Danlos syndrome, spondylodysplastic type, 2
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome, with progressive kyphoscoliosis, myopathy, and hearing loss -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03408">
   Ehlers-Danlos syndrome, kyphoscoliotic type, 2
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome with short stature and limb anomalies -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00435">
   Ehlers-Danlos syndrome, spondylodysplastic type, 1
  </a>
 </li>
 <li>
  Ehlers-Danlos syndrome-like spondylocheirodysplasia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01517">
   Ehlers-Danlos syndrome, spondylodysplastic type, 3
  </a>
 </li>
 <li>
  Encephalopathy, acute, infection-induced (herpes-specific) 8 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05212">
   Encephalopathy, acute, infection-induced, herpes-specific, 8
  </a>
 </li>
 <li>
  Erythropoietic protoporphyria -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00484">
   Protoporphyria, erythropoietic, 1
  </a>
 </li>
 <li>
  Herpes simplex encephalitis 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02573">
   Encephalopathy, acute, infection-induced, Herpes-specific, 1
  </a>
 </li>
 <li>
  Herpes simplex encephalitis 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02371">
   Encephalopathy, acute, infection-induced, Herpes-specific, 2
  </a>
 </li>
 <li>
  Herpes simplex encephalitis 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03543">
   Encephalopathy, acute, infection-induced, Herpes-specific, 5
  </a>
 </li>
 <li>
  Herpes simplex encephalitis 4 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03544">
   Encephalopathy, acute, infection-induced, Herpes-specific, 6
  </a>
 </li>
 <li>
  Herpes simplex encephalitis 7 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04529">
   Encephalopathy, acute, infection-induced, Herpes-specific, 7
  </a>
 </li>
 <li>
  Hydrocephalus, non-syndromic, autosomal recessive 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03639">
   Hydrocephalus, congenital, 1
  </a>
 </li>
 <li>
  Hydrocephalus, non-syndromic, autosomal recessive 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03725">
   Hydrocephalus, congenital, 2, with or without brain or eye anomalies
  </a>
 </li>
 <li>
  Hyperphosphatasia with mental retardation syndrome 5 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04229">
   Glycosylphosphatidylinositol biosynthesis defect 11
  </a>
 </li>
 <li>
  Hypomagnesemia 5 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00575">
   Hypomagnesemia 5, renal, with or without ocular involvement
  </a>
 </li>
 <li>
  IL21R immunodeficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03764">
   Immunodeficiency 56
  </a>
 </li>
 <li>
  Isolated sulfite oxidase deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01843">
   Sulfite oxidase deficiency, isolated
  </a>
 </li>
 <li>
  May-Hegglin anomaly -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01951">
   Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
  </a>
 </li>
 <li>
  Methemoglobinemia CYB5A-related -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02720">
   Methemoglobinemia and ambiguous genitalia
  </a>
 </li>
 <li>
  Methylmalonic aciduria and homocystinuria type cblD -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00745">
   Methylmalonic aciduria and homocystinuria, cblD type
  </a>
 </li>
 <li>
  Methylmalonic aciduria and homocystinuria type cblC -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00744">
   Methylmalonic aciduria and homocystinuria, cblC type
  </a>
 </li>
 <li>
  Methylmalonic aciduria and homocystinuria type cblF -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00746">
   Methylmalonic aciduria and homocystinuria, cblF type
  </a>
 </li>
 <li>
  Nakajo syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03009">
   Proteasome-associated autoinflammatory syndrome 1
  </a>
 </li>
 <li>
  Natural killer cell and glucocorticoid deficiency with DNA repair defect -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03605">
   Immunodeficiency 54
  </a>
 </li>
 <li>
  Polycystic kidney disease 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00925">
   Polycystic kidney disease 1 with or without polycystic liver disease
  </a>
 </li>
 <li>
  Polycystic kidney disease 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00926">
   Polycystic kidney disease 2 with or without polycystic liver disease
  </a>
 </li>
 <li>
  Polycystic kidney disease 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04789">
   Polycystic kidney disease 3 with or without polycystic liver disease
  </a>
 </li>
 <li>
  Polycystic kidney disease 4, with or without hepatic disease -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00927">
   Polycystic kidney disease 4, with or without polycystic liver disease
  </a>
 </li>
 <li>
  Polycystic liver disease 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02175">
   Polycystic liver disease 1 with or without kidney cysts
  </a>
 </li>
 <li>
  Polycystic liver disease 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04751">
   Polycystic liver disease 2 with or without kidney cysts
  </a>
 </li>
 <li>
  Pro-opiomelanocortinin deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02211">
   Obesity, early-onset, with adrenal insufficiency and red hair
  </a>
 </li>
 <li>
  Shwachman-Diamond syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02303">
   Shwachman-Diamond syndrome 1
  </a>
 </li>
 <li>
  Tetraamelia syndrome, autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01262">
   Tetraamelia syndrome 1
  </a>
 </li>
 <li>
  Transposition of the great arteries dextro-looped 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03082">
   Congenital heart defects, multiple types, 6
  </a>
 </li>
 <li>
  Tumoral calcinosis, hyperphosphatemic, familial -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00573">
   Tumoral calcinosis, hyperphosphatemic, familial, 1
  </a>
 </li>
 <li>
  Weill-Marchesani-like syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02827">
   Weill-Marchesani syndrome 4
  </a>
 </li>
</ul>
<p>
 Deleted diseases
</p>
<ul>
 <li>
  Alport syndrome, with macrothrombocytopenia
 </li>
 <li>
  Bannayan-Riley-Ruvalcaba syndrome
 </li>
 <li>
  Cowden syndrome 2
 </li>
 <li>
  Cowden syndrome 3
 </li>
 <li>
  Epstein syndrome
 </li>
 <li>
  Fechtner syndrome
 </li>
 <li>
  Macrothrombocytopenia and progressive sensorineural deafness
 </li>
 <li>
  Sebastian syndrome
 </li>
</ul>
<h3 id="Changes_to_the__a_href___docs_ptmlist__controlled_vocabulary_for_PTMs__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/ptmlist">
  controlled vocabulary for PTMs
 </a>
</h3>
<p>
 New terms for the feature key 'Modified residue' ('MOD_RES' in the flat file):
</p>
<ul>
 <li>
  (2S)-4-hydroxyleucine
 </li>
 <li>
  (3S)-3-hydroxylysine
 </li>
 <li>
  (4S)-4,5-dihydroxyleucine
 </li>
 <li>
  2-hydroxyproline
 </li>
 <li>
  3',4',5'-trihydroxyphenylalanine
 </li>
 <li>
  4-hydroxylysine
 </li>
</ul>
<p>
 Modified term for the feature key 'Modified residue' ('MOD_RES' in the flat file):
</p>
<ul>
 <li>
  Hydroxylated arginine -&gt; Hydroxyarginine
 </li>
</ul>
<h2 id="UniProt_website_news">
 UniProt website news
</h2>
<h3 id="Deprecation_of_legacy_REST_URLs__batch_and__mapping___please_replace_by__uploadlists">
 Deprecation of legacy REST URLs /batch and /mapping - please replace by /uploadlists
</h3>
<p>
 Programmatic access to our "Retrieve/IDmapping" service should be addressed to the URL path
 <code>
  /uploadlists
 </code>
 as shown in the code examples in the respective service help pages
 <a href="http://www.uniprot.org/help/api%5Fidmapping">
  ID mapping
 </a>
 and
 <a href="http://www.uniprot.org/help/api%5Fbatch%5Fretrieval">
  Batch retrieval
 </a>
 .
</p>
<p>
 If you have existing code for batch retrieval, you also need to specify that you are mapping to and from UniProtKB, i.e.
</p>
<pre>'from' =&gt; 'ACC+ID',
'to' =&gt; 'ACC',
</pre>
<p>
 (See the Perl code example in
 <a href="http://www.uniprot.org/help/api%5Fbatch%5Fretrieval">
  Batch retrieval
 </a>
 .)
</p>
<p>
 The obsolete URL paths
 <code>
  /batch
 </code>
 and
 <code>
  /mapping
 </code>
 have been deprecated and are no longer supported as of release 2018_09.
</p>